Table 2.2.

Subgroup analysis for tumor response in patients with stage IB1-IVB

Stage	Parameter	N (%)
IB1-IVA	Complete Response (CR)	4 (11.1)
	Partial Response (PR)	28 (77.8)
	Stable Disease (SD)	1 (2.8)
	Progressive Disease (PD)	3 (8.3)
	ORR (CR + PR), 95%CI	32 (88.9), 73.9–96.9
	DCR (CR + PR + SD), 95%CI	33 (91.7), 77.5–98.2
IVB	Complete Response (CR)	5 (13.5)
	Partial Response (PR)	22 (59.5)
	Stable Disease (SD)	6 (16.2)
	Progressive Disease (PD)	4 (10.8)
	ORR (CR + PR), 95%CI	27 (73.0), 55.9–86.2
	DCR (CR + PR + SD), 95%CI	33 (89.2), 74.6–97.0

Data are presented as N (%) unless otherwise specified. Responses were assessed in accordance with RECIST version 1.1. Only confirmed responses were included

ORR, overall response rate; DCR, disease control rate; CI, confidence interval